>>> Ralph Lauren up 8% at six month high following earnings: Additional call not

Ralph Lauren up 8% at six month high following earnings: Additional call notes
  • Ecommerce comps were down mid-single digits (better in Europe) due to decreased promotions; sees mid to high single digit decrease in comps for same reasons.
  • Co is delvoping flagship ecommerce platform, which will become very important part of business.
  • Co is cutting lead times.
  • SG&A savings will be weighted to 2H.
  • Europe comps fell low single digits.
RL at six month high after reproting first quarter since announcing Way Forward Plan (restructuring). Mgmt set expectations appropriately low in early June and upside Q2 sales guidance has been well received as co focues on improving margins.

>>> US Gapping Up

Gapping up
In reaction to strong earnings/guidance
:
  • CLNE +19.2%, OPGN +15.4%, ADVM +12.7%, YELP +12.6%, SUNW +10.7%, VRNS +9.6%, DXPE +8.9%, BBSI +8.6%,COTV +7.7%, DHT +7.7%, NH +7.3%, YRD +7.3%, HCHC +7%, WATT +6.7%, (also announces $20 mln private placement), RL +6.6%, INFI +5.6%, CDXS +5.3%
  • LITE +4.9%, HALO +4.8%, RYI +4.4%, JD +4.1%, XONE +3.7%, CEL +3.7%, OXLC +3.4%, HLIT +3.3%, CRME +3.2%, (also XYDALBA has been approved by the EMA for administration as a single, 30 minute, 1500mg infusion), AG +3.1%, ICLD+2.9%, CPRX +2.8%, ARMK +2.7%, PUK +2.5%, EDIT +2.4%, TCS +2.4%
  • TAHO +1.9%, OTIV +1.8%, WAGE +1.7%, RBCN +1.7%, ICL +1.5%, PTLA +1.1%, AEZS +1.1%, IEC +1%
Select metals/mining stocks trading higher: EGO +4.9%, MUX +4.4%, BTG +4%, GFI +3.9%, KGC +3.9%, SWC +3.3%,CDE +3.2%, HL +3.1%, FCX +3%, SLV +2.9%, ABX +2.8%, GDX +2.7%, GOLD +2.6%, AU +2.6%, GG +2.5%, AUY +2.3%,NEM +2.2%, MT +1.6%, BHP +1.5%, IAG +1.2%, GLD +1.1%

Other news:
  • APRI +27.9% (announces that Ferring Pharmaceuticals, the Company's new partner in Germany, has received the German marketing authorization for Vitaros)
  • VTVT +15.5% (announces 'positive' topline results from a Phase 2b study of TTP399; achieves primary endpoint)
  • CBMX +12.3% (announces that Universal Diagnostic Labs will market and distribute its chromosomal microarray miscarriage analysis test in both Northern and Southern California)
  • VSAR +11.5% (Versartis and Teijin LImited enter into an exclusive license and supply agreement for the development and commercialization of somavaratan in Japan; will receive an upfront payment of $40 million )
  • PLX +11.1% (announces additional 'positive' data from its phase I/II clinical trial of PRX-102 for the treatment of Fabry disease)
  • OCN +7.9% (S&P raised its ranking on Ocwen Loan Servicing LLC Commercial Servicer, Ocwen Loan Servicing LLC Residential Master Servicer to Average)
  • KTOV +6.8% (receives US patent for its lead drug candidate KIT-302)
  • TOPS +5.9% (announces delivery of sixth newbuilding vessel & completion of six-vessel newbuilding program)
  • JBLU +1.6% (reports July 2016 prelim traffic)
Analyst comments:
  • ZIOP +6.4% (upgraded to Market Perform from Underperform at Wells Fargo
  • SSL +3.1% (upgraded to Overweight from Equal Weight at Morgan Stanley)
  • ASPS +2.7% (upgraded to Buy at Compass Point)
  • PHG +2.2% (upgraded to Buy from Neutral at UBS)

>>> US Gapping down

Gapping down
In reaction to disappointing earnings/guidance
:
  • GEVO -32.6%, MYGN -30%, SPWR -29%, (also announces restructuring due to industry conditions), WGBS -24.8%, TDW-17%, (updates status of discussions with lenders / noteholders ), PRGO -12.7%, YUME -10.2%
  • SIF -9.4%, GALE -7%, CYBR -5.5%, DPLO -5.1%, LSCC -4.8%, ARWR -4.5%, OHRP -4.4%, CALL -4.3%, ALDX -4.2%,KORS -4.2%, SEDG -3.8%, OA -3.8%, WEN -3.8%, CALA -3.4%, VSAT -3.3%
  • OMER -2.8%, SPPI -2.1%, NVAX -2%, HTM -1.8%, CTSO -1.8%, (thinly traded), DIS -1.4%, (also Acquires Minority Stake in BAMTech; Disney Investment will Accelerate Growth of Leading Technology and Direct-To-Consumer Video Streaming Company), MATR -1.4%, SPHS -1.4%, JAZZ -1%
Other news:
  • GBSN -9.1% (discloses further issuance of shares to certain holders of its 2015 Notes)
  • RPRX -8.6% (light volume; enters into equity distribution agreement to offer and sell up to $10 mln in shares of common stock)
  • CSIQ -5.5% (following SPWR earnings/guidance/restructuring news)
  • X -4.2% (priced 18.9 mln shares common stock offering (upsized from 17 mln) at a public offering price of $23/share), FSLR-3.6% (following SPWR earnings/guidance/restructuring news)
  • CLF -3.4% (announces underwritten public offering of $300 mln of its common shares)
  • JKS -3.2% (in sympathy with SPWR earnings)
  • ZBH -3.1% (pricing of a ~7.44 mln share secondary common stock offering at $129.75/share by selling shareholders)
  • LY -2.9% (updates on Monarch 2 phase 3 trial of Abemaciclib; an independent Data Monitoring Committee recommended to continue the study without modification as the interim efficacy criteria were not me)
  • VWR -2.8% ( commences 8 mln common stock offering by selling stockholder Varietal Distribution Holdings )
  • LOAN -1.8% (prices underwritten public offering of 672,269 common shares at a price to the public of $5.95 per share)
  • CONE -1.7% (CyrusOne commenced the public offering of 6.8 mln shares of common stock-including 3.4 mln by the Forward Purchaser or its affiliate in connection with the forward sale agreement )
  • PANW -1.2% (following CYBR earnings)
  • TSL -1.1% (following SPWR earnings/guidance/restructuring news)
Analyst comments:
  • NE -2.4% (downgraded to Sell from Hold at Argus)
  • RBS -0.8% (downgraded to Hold from Buy at Investec)

WSJ : Bank of England to Make Up Bond-Purchasing Shortfall After Auction Hiccup


Bank of England to Make Up Bond-Purchasing Shortfall After Auction Hiccup

The BOE revived its crisis-era bond-buying program as part of a package of measures to support the economy in the wake of Brexit

LONDON—The Bank of England said Wednesday it plans to make up a shortfall in its bond-purchase program later this year after it couldn’t find enough bonds to buy in a Tuesday auction, an unusual hiccup that analysts say probably won’t become the norm.
The BOE revived its crisis-era bond-buying program on Thursday as part of a package of measures to support the economy in the wake of voters’ decision to exit the European Union. It said it would buy £60 billion ($78 billion) of U.K. government bonds, or gilts, over the next six months, a policy known as quantitative easing. The aim is to drive down long-term interest rates and prod investors into riskier assets, making borrowing cheaper and easier for businesses and households.
The BOE’s first foray into the market in its latest round of QE went off Monday without a hitch. But on Tuesday, it said that it was only able to buy £1.12 billion of the £1.17 billion of the bonds it had hoped to scoop up.
On Wednesday, it said the roughly £50 million shortfall would be made up in the second half of its six-month buying spree.
The reason for the shortfall wasn’t entirely clear. Analysts said on Wednesday the snafu probably reflected in part the nature of the bonds the BOE was trying to buy. The central bank holds auctions for bonds of different maturities on different days; on Tuesday it wanted to buy bonds maturing in 15 years or more.

Such bonds are highly prized by pension funds and other long-term investors, which covet them to match their future liabilities as they fall due, said Luke Hickmore, senior investment manager at Aberdeen Asset Management PLC. That might make them “challenging to get hold of,” Mr. Hickmore said.
Others offered more mundane explanations. Alan Clarke, director of fixed income research at Scotiabank, said the traditional mid-August lull in London’s financial markets probably meant some senior bond dealers were away from their desks, leaving decisions in the hands of junior staff unsure how to deal with the central bank. He added bond prices will likely rise as the BOE’s purchases get into full swing, so dealers won’t have felt in any rush to sell in the first days of the six-month program.
“Why sell early on and miss out on the upside?” he said.
U.K. government bond prices rose on Wednesday following the auction mishap, driving yields higher. After falling below 0.6% Tuesday for the first time in history, yields on 10-year U.K. sovereign bonds touched a new record-low of 0.523% Wednesday.
The BOE is due to purchase 10-year gilts Wednesday as part of a basket of assets maturing between seven and 15 years. The outcome of the so-called reverse auction, where the BOE sellers to submit bids and rejects those it doesn’t like, will be published later Wednesday. The BOE will seek 15-year debt again next week.

>>> Ralph Lauren beats by $0.17, beats on revs; guides Q2 rev above consensus; r

RL +5.24% @ 100.05 vs 95.07

Ralph Lauren beats by $0.17, beats on revs; guides Q2 rev above consensus; reaffirms FY17 outlook

  • Reports Q1 (Jun) earnings of $1.06 per share, excluding non-recurring items, $0.17 better than the Capital IQ Consensus of $0.89; revenues fell 4.1% year/year to $1.55 bln vs the $1.53 bln Capital IQ Consensus. The decline in reported net revenues was in line with the guidance provided in June of a mid-single digit revenue decline.
    • On a reported basis, international net revenue rose 10% in the first quarter, offset by an 11% decline in North America.
    • Wholesale Revenue. In the first quarter of Fiscal 2017, wholesale segment revenue decreased 5% on both a reported and constant currency basis to $607 million, driven by a decline in North America as the U.S. department store channel continued to experience challenging traffic trends, partially offset by an increase in Europe.
    • Retail Revenue. Retail segment revenue decreased 3% on both a reported and constant currency basis to $907 million in the first quarter, driven by a comparable store sales decline that was partially offset by non-comparable store sales growth. Consolidated comparable store sales decreased 6% on a reported basis and 7% in constant currency during the first quarter, primarily due to lower traffic trends.
  • Co sees Q2 rev down mid to high single digits vs. -10% consensus; Operating margin for the second quarter of Fiscal 2017 is expected to be 200-250 basis points below the comparable prior year period. Initiatives under the Way Forward Plan are expected to have a greater impact in the second half of Fiscal 2017 than the second quarter.
  • For Fiscal 2017, the co continues to expect consolidated net revenues to decrease at a low-double digit rate due to a proactive pullback in inventory receipts, store closures, pricing harmonization and other quality of sale initiatives, combined with the weak retail traffic and a highly promotional environment in the U.S. Based on current exchange rates, FX will have minimal impact on revenue growth in Fiscal 2017. The co continues to expect operating margin for Fiscal 2017 to be ~10%, as cost savings are expected to be offset by growth in new store expenses, unfavorable foreign currency impacts, infrastructure investments and fixed expense deleverage.